Dyne Therapeutics Inc
NASDAQ:DYN

Watchlist Manager
Dyne Therapeutics Inc Logo
Dyne Therapeutics Inc
NASDAQ:DYN
Watchlist
Price: 20.35 USD -0.29% Market Closed
Market Cap: 2.9B USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of DYN.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DYN Intrinsic Value
Not Available
Base Case Scenario
Compare DYN to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about DYN?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Dyne Therapeutics Inc

Current Assets 806.3m
Cash & Short-Term Investments 791.9m
Other Current Assets 14.4m
Non-Current Assets 60.8m
PP&E 45.8m
Other Non-Current Assets 15m
Current Liabilities 59.8m
Accounts Payable 12.1m
Accrued Liabilities 47.8m
Non-Current Liabilities 115.4m
Long-Term Debt 99.1m
Other Non-Current Liabilities 16.3m
Efficiency

Free Cash Flow Analysis
Dyne Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Dyne Therapeutics Inc

Revenue
0 USD
Operating Expenses
-449.2m USD
Operating Income
-449.2m USD
Other Expenses
25.4m USD
Net Income
-423.8m USD
Fundamental Scores

DYN Profitability Score
Profitability Due Diligence

Dyne Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Declining ROE
Low 3Y Average Operating Margin
hidden
Profitability
Score

Dyne Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

DYN Solvency Score
Solvency Due Diligence

Dyne Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
hidden
Solvency
Score

Dyne Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DYN Price Targets Summary
Dyne Therapeutics Inc

Wall Street analysts forecast DYN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DYN is 39.97 USD with a low forecast of 17.17 USD and a high forecast of 63 USD.

Lowest
Price Target
17.17 USD
16% Downside
Average
Price Target
39.97 USD
96% Upside
Highest
Price Target
63 USD
210% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dyne Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for DYN is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

DYN Insider Trading
Buy and sell transactions by insiders